IE
MRNA icon

Israel Englander’s Moderna MRNA Stock Holding History

Israel Englander’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.11M Buy
115,800
+68,300
+144% +$3.53M ﹤0.01% 2512
2026
Q1 		$2.41M Sell
47,500
-76,100
-62% -$3.55M ﹤0.01% 3690
2025
Q4 		$3.64M Sell
123,600
-452,500
-79% -$12.3M ﹤0.01% 3357
2025
Q3 		$14.9M Buy
576,100
+162,100
+39% +$4.52M 0.01% 1987
2025
Q2 		$11.4M Buy
414,000
+238,800
+136% +$6.29M 0.01% 2124
2025
Q1 		$4.97M Buy
175,200
+29,700
+20% +$1.05M ﹤0.01% 2870
2024
Q4 		$6.05M Buy
145,500
+8,600
+6% +$411K ﹤0.01% 2655
2024
Q3 		$9.15M Sell
136,900
-269,500
-66% -$24.7M ﹤0.01% 2255
2024
Q2 		$48.3M Buy
406,400
+183,900
+83% +$23.3M 0.02% 818
2024
Q1 		$23.7M Sell
222,500
-5,800
-3% -$585K 0.01% 1426
2023
Q4 		$22.7M Sell
228,300
-34,000
-13% -$2.86M 0.01% 1443
2023
Q3 		$27.1M Buy
262,300
+112,400
+75% +$12.5M 0.01% 1177
2023
Q2 		$18.2M Sell
149,900
-35,300
-19% -$4.71M 0.01% 1471
2023
Q1 		$28.4M Buy
185,200
+48,000
+35% +$7.92M 0.02% 1076
2022
Q4 		$24.6M Sell
137,200
-18,800
-12% -$3.07M 0.01% 1264
2022
Q3 		$18.4M Buy
156,000
+15,400
+11% +$2.34M 0.01% 1429
2022
Q2 		$20.1M Sell
140,600
-31,600
-18% -$4.52M 0.01% 1305
2022
Q1 		$29.7M Buy
172,200
+26,900
+19% +$4.53M 0.02% 1025
2021
Q4 		$36.9M Buy
145,300
+35,300
+32% +$10.3M 0.02% 930
2021
Q3 		$42.3M Sell
110,000
-90,000
-45% -$33.2M 0.03% 736
2021
Q2 		$47M Buy
200,000
+100,000
+100% +$17.9M 0.03% 639
2021
Q1 		$13.1M Buy
100,000
+71,000
+245% +$10.3M 0.01% 1504
2020
Q4 		$3.03M Buy
29,000
+19,000
+190% +$1.92M ﹤0.01% 2889
2020
Q3 		$708 Buy
+10,000
New +$697K ﹤0.01% 3370

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Israel Englander's MRNA Position: Q2 2026 in Review

Israel Englander reduced its Moderna (MRNA) stake by 57% in Q2 2026, selling an estimated $30M and leaving 438,615 shares worth $30.7M. The position accounts for 0.01% of the portfolio, ranked #1256.

Israel Englander first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $98.4M in Q2 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Israel Englander held 438,615 shares of Moderna worth $30.7M as of Q2 2026.
  • Israel Englander sold 580,593 Moderna shares in Q2 2026, an estimated $30M.
  • Moderna made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1256 holding.
  • Israel Englander first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
  • Israel Englander's Moderna position peaked at $98.4M in Q2 2021.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.